I’ll never forget the first time I realized public health in America was about to change forever. It wasn’t in D.C. or at some think tank — it was live, on the airwaves, during a call with Dr. Marty Makary.
This is a voice you might recognize from the dark days of COVID — a Johns Hopkins cancer surgeon and best-selling author who stood up for truth when the whole country was being told to sit down and shut up.
Dr. Makary didn’t just challenge conventional wisdom. He called for a renewed emphasis on common sense and humility. He wasn’t pushing an agenda; he was safeguarding America’s future.
But this moment? It’s even bigger. Today, we’re witnessing a revolution in health, driven not by pencil pushers, but by a new alliance: Robert F. Kennedy Jr. — Secretary of Health and Human Services — and FDA Commissioner Makary.
The old days of Big Ag controlling what’s on the dinner table… “experts” rubber-stamping vaccines… and high-salaried public health officials demanding compliance are over.
Instead, we’ve entered the era of “Make America Healthy Again” (MAHA): a data-driven movement tearing down decades-old barriers in prevention, food safety, and patient-centered care.
And here’s the promise: This isn’t just changing the face of medicine. It’s opening a floodgate of opportunity for you as a patriot and investor.
The Chronic Disease Epidemic
For decades, the system was designed for Big Ag and Big Pharma’s profit, not for your family’s protection.
This corrupted the very foundation of public health and paved the way for a chronic disease epidemic that’s now raging across America:
- Over 40% of U.S. children live with at least one chronic health condition, according to the CDC’s 2024 National Survey of Children’s Health.
- Healthcare spending is projected to hit $4.9 trillion in 2025, consuming nearly 20% of the nation’s GDP.
- Most of that spending is on preventable diseases like Type 2 diabetes, hypertension, and heart disease — which now afflict almost half of all American adults.
How did we get here? The real causes are obvious: ultra-processed foods, environmental toxins, ever-increasing sedentary lifestyles, and, yes, even vaccine overreach fueled by unaccountable bureaucrats.
Take Dr. Anthony Fauci as a glaring example of what’s wrong with the system. While everyday Americans suffered under extended pandemic lockdowns and aggressive vaccine policies, Fauci walked away with a presidential pardon, a lucrative book deal and speaking engagements that netted him millions.
Enrichments hardly befitting a man whose policies left so many questioning the public health establishment’s credibility, I’ll add.
But something seismic changed in early 2025. The MAHA movement immediately set its sights on a medical system that’s allergic to prevention. And on the root causes crippling the nation.
The “Food As Medicine” Revolution
It started in February 2025 with Executive Order 14212, signed by President Trump and spearheaded by Secretary RFK Jr. The order established a presidential commission tasked with nothing less than overhauling America’s food supply.
The targets were clear: seed oils, high-fructose corn syrup, and petroleum-based food dyes — ingredients long banned in Europe and much of Asia, yet ingredients still found in American pantries.
The administration didn’t mince words. In the rollout of MAHA, Kennedy called much of today’s food system “toxic by design.”
One prime example? Yellow #5, also known as tartrazine — a synthetic dye originally derived as a byproduct of the petroleum industry.
It’s been linked to hyperactivity and allergic reactions in children and is banned or restricted in several countries. Yet it remains an additive in hundreds of foods marketed to American kids, from breakfast cereals to mac-and-cheese. It has no nutritional value and no defensible place in the modern food supply.
Now, for the first time in memory, the federal government is finally treating what’s in our food as the national emergency it is. Ingredients like tartrazine are being phased out of the U.S. food supply by the end of next year.
Change is happening. School lunch programs are being rewritten to serve whole foods instead of ultra-processed carbs and mystery ingredients.
Tax breaks for gym memberships and wellness spending aren’t fringe ideas anymore — they’re gaining traction as part of a broader shift: reward healthy choices, stop subsidizing preventable illnesses.
And at the state level, legislatures in Florida, Texas, and Ohio are already pushing forward MAHA-aligned bills that turn everyday decisions — like what you feed your kids or how you stay active — into part of a long-term national health solution.
The “food as medicine” revolution is no longer just aspirational. As FDA Commissioner Makary puts it: “People forget that the F in FDA stands for food… We’re investing in the food side of the FDA.”
The FDA’s Comeback: Cutting Red Tape, Embracing Technology
If you really want to see where MAHA has teeth — just look inside the Food and Drug Administration, where Dr. Marty Makary is cleaning house.
As he told me recently: “We’re changing the entire approach to healthcare in the United States under Secretary Kennedy.”
It’s not just rhetoric. Makary is implementing a structural overhaul that many in the biotech and pharmaceutical industries thought impossible:
- Slashing drug approval timelines from a decade — and over $2B in R&D — to a matter of months
- And deploying artificial intelligence (AI) to process hundreds of thousands of pages of medical research in minutes, not months.
A concrete example? In 2024, the FDA began broader use of the “Real-Time Oncology Review” (RTOR) program for breakthrough cancer drugs.
Leveraging AI analytics, review teams processed data for critical therapies like Amgen’s Blincyto and Janssen’s Rybrevant — which treat forms of leukemia and lung cancer respectively — at record speeds. What once took years of bureaucracy compressed into a few months, without sacrificing safety.
But that’s just oncology. AI is also supercharging drug safety tracking. The FDA’s Sentinel Initiative now integrates machine learning to monitor real-world evidence from millions of Americans’ medical records.
When COVID vaccine myocarditis cases started appearing, for instance, it was AI pattern recognition in the Sentinel system that helped the agency spot it and act swiftly — issuing warnings and requiring updated labeling within weeks, rather than years.
And the “Patient First” payoff isn’t only in speed. AI review means regulators can now spot rare but catastrophic side effects across massive datasets that once went unparsed.
That’s why the FDA recently greenlit several early-access programs for Alzheimer’s and ALS therapies, using predictive analytics to identify patients who’ll benefit most — not just those who fit the “typical” profile.
The FDA under Makary is a leaner operation, and leaning into technology to hunt for breakthroughs on everything from ALS to a universal flu shot.
Rehabilitating American Healthcare
This health revolution isn’t a distant promise — it’s happening right now. The long-standing bureaucracy that once choked innovation at the FDA is being uprooted by a clear-eyed combination of cutting-edge technology and common sense.
The shift on COVID vaccine policy illustrates the point perfectly. After years of blind mandates, the FDA under Dr. Makary’s leadership is now demanding rigorous U.S.-based trials before approving shots for healthy children.
The fact that almost 70–85% of healthcare workers refused the latest COVID booster sends a clear message about the public’s demand for transparency and a return to what Dr. Makary calls “gold standard” medicine.
Beyond the FDA, the “Make America Healthy Again” movement is sparking profound shifts across corporate America and healthcare systems, confronting the chronic disease epidemic head-on.
This isn’t about alleviating symptoms — it’s about cutting out the root causes of preventable illnesses.
Technology is the engine behind this transformation. Artificial intelligence is slicing drug review times, analyzing vast data in minutes, and guiding new therapies to those who need them most. From cancer to ALS to Alzheimer’s, we’re witnessing a pivot toward precision and prevention.
What’s emerging is a healthcare paradigm built on science, speed, and sanity — trading mandates for empowerment, and red tape for results.
This revolution will save lives and mark a seismic shift in the American economy, creating fresh opportunities for investors and patriots ready to back the country’s biggest health comeback in generations.
